ASP Isotopes Inc. Common Stock

Ms. Heather  Kiessling

Chief Financial Officer

Mr. Robert  Ainscow

Chief Operating Officer

Dr. Gerdus  Kemp M.D., Ph.D.

Medical Director & Chief Executive Officer of Pet Labs

Mr. Hendrik T. van Wyk

Head of Engineering

Mr. Paul Elliot Mann C.F.A.

President, Chief Executive Officer & Executive Chairman

Dr. Hendrik  Strydom B. Sc, M. Sc, Ph.D.

Chief Technology Officer & Director

Dr. Xandra van Heerden Ph.D.

Head of Research & Development

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.

SAN FRANCISCO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company deceived investors by making false and misleading statements about its advanced nuclear fuel technologies.

ASP Isotopes (ASPI) Accused of Deceiving Investors with Bogus Nuclear Tech Claims– Hagens Berman

Lead Plaintiff Deadline is February 3, 2025 CLICK HERE TO PROVIDE CONTACT INFORMATION AND JOIN THE CASE NEW YORK , Dec. 23, 2024 /PRNewswire/ --  Wolf Haldenstein Adler Freeman & Herz LLP  ("Wolf  Haldenstein") announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of persons and entities that purchased or otherwise acquired ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI) securities between  October 30, 2024 and November 26, 2024 , inclusive (the "Class Period"). CLICK HERE TO PROVIDE CONTACT INFORMATION AND JOIN THE CASE A ll investors who purchased shares and incurred losses are advised  to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.

ASP Isotopes Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against ASP Isotopes Inc.

NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=118120&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 3, 2025 in ASP Isotopes Inc. Lawsuit - ASPI

NEW YORK, NY / ACCESSWIRE / December 23, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ASP Isotopes securities between October 30, 2024 and November 26, 2024, both dates inclusive (the "Class Period").

ASPI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of ASP Isotopes Inc. to Contact the Firm Today!

NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=118093&wire=1 or contact Joseph E. Levi, Esq.

ASP Isotopes Inc. Common StockASPI

ASP Isotopes Inc. Common Stock
ASPI